Simona Daciana Birsan

Dr. Simona Daciana Birsan

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
KBKaroly Bancsik
Karoly Bancsik
CICodrin Dan Nicolae Ilea
Codrin Dan Nicolae Ilea
MDMădălina Diana Daina
Mădălina Diana Daina
RBRaluca Bancsik
Raluca Bancsik
CSCORINA SUTEU
CORINA SUTEU
LDLucia Georgeta Daina
Lucia Georgeta Daina
(1) Background: The study aimed to assess the patients’ perception of the quality of the medical staff’s care, the hotel’s services, and the hospital’s overall impression as well as to determine the best rating scale through a comparative analysis of patient satisfaction questionnaires. (2) Methods: A retrospective study was performed based on satisfaction questionnaires addressed to the patients hospitalized in the Orthopedics and Traumatology departments of the County Clinical Emergency Hospital Oradea between 2015 and 2019. Three different types of questionnaires were used during the study period, with the number of questions varying between 30 (variant A) and 37 (variant C). The evaluation was done using the Likert scales with three, four, or five answer variables. (3) Results: The items that we found to be present in all three categories of surveys and for which at least two different questionnaire variants used the Likert scales with various answer variables were chosen. In terms of the treatment given by the medical staff, hotel services, and the overall perception of the hospital, the patients perceive a higher level of quality. (4) Conclusions: The level of patient overall satisfaction or general impression about the hospital is strongly dependent on the quality of medical care provided by the doctors and the specific hotel conditions of the hospital. The quality assessment using the Likert rating scale with five binary variables is more accurate.

23 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MFMădălina Diana Fehér
Mădălina Diana Fehér
CICodrin Dan Nicolae Ilea
Codrin Dan Nicolae Ilea
Cosmin Mihai VesaCosmin Mihai Vesa
Cosmin Mihai Vesa
AVAlina Venter
Alina Venter
SBSimona Daciana Birsan
Simona Daciana Birsan
CDCristian Marius Daina
Cristian Marius Daina
Background and Objectives: Diabetes mellitus (DM) is a highly prevalent comorbidity among critically ill patients and may significantly influence intensive care unit (ICU) outcomes through metabolic, immune, and cardiovascular mechanisms. This study aimed to evaluate the impact of DM on clinical profile, comorbidities, complications, need for intensive support, and mortality in adult ICU patients. Materials and Methods: A retrospective observational study was conducted between January and December 2024 in a tertiary ICU, including 1344 adult patients. Among them, 435 (32.37%) had DM. Demographic data, admission diagnoses, laboratory parameters, comorbidities, complications, therapeutic interventions, and outcomes were analyzed. Comparative statistical analysis and multivariate logistic regression were performed to identify independent predictors of ICU mortality. Results: Patients with DM were significantly older than patients without diabetes mellitus (non-DM group) (69.62 ± 10.26 vs. 67.16 ± 14.26 years, p < 0.001) and more frequently female (57%, p = 0.0002). At admission, they presented higher glycemia (204.7 vs. 134.0 mg/dL, p < 0.00001), reduced glomerular filtration rate (47.2 vs. 59.5 mL/min/1.73 m2, p < 0.00001), and more pronounced lymphocytopenia (p = 0.025). Cardiovascular and renal comorbidities were significantly more prevalent in DM, including hypertension (76.3%), heart failure (32.4%), and chronic kidney disease (33.1%) (all p < 0.01). DM was associated with increased odds of sepsis (OR 1.56), acute kidney injury (OR 1.51), and obesity (OR 2.57). ICU mortality was significantly higher in patients with DM (54.9% vs. 46.3%, p = 0.004; RR 1.19). Independent predictors of death included mechanical ventilation (OR 36.48), inotropic therapy (OR 4.74), hemodialysis (OR 2.57), elevated lactate, neutrophilia, and reduced glomerular filtration rate (GFR). Conclusions: DM was associated with increased ICU mortality and a higher burden of cardio-renal comorbidities and complications; however, mortality in the multivariate model was primarily driven by markers of organ dysfunction and the need for advanced supportive therapies. Early risk stratification and individualized management strategies are essential to improve outcomes in critically ill patients with diabetes.

6 August 2026 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
MFMădălina Diana Fehér
Mădălina Diana Fehér
CICodrin Dan Nicolae Ilea
Codrin Dan Nicolae Ilea
Cosmin Mihai VesaCosmin Mihai Vesa
Cosmin Mihai Vesa
AVAlina Venter
Alina Venter
SBSimona Daciana Birsan
Simona Daciana Birsan
CDCristian Marius Daina
Cristian Marius Daina
Background: Glycemic dysregulation is frequent in critically ill patients and may influence prognosis regardless of pre-existing diabetes status. This study aimed to evaluate the impact of glycemic status and glycemic variability on mortality and morbidity in diabetic and non-diabetic patients admitted to the intensive care unit (ICU). Methods: This prospective observational study included 244 critically ill patients. Demographic, clinical, biological, and glycemic data were collected during ICU hospitalization. Glycemic parameters included admission glucose, mean glucose, glucose standard deviation, coefficient of glycemic variability, hyperglycemia > 140 mg/dL, hyperglycemia > 180 mg/dL, hypoglycemia < 70 mg/dL, and intravenous insulin requirement. The primary outcome was in-hospital mortality. Results: In-hospital mortality was 58.6%. Non-survivors had significantly higher admission glucose, mean glucose, glycemic standard deviation, and coefficient of glycemic variability compared with survivors. Hyperglycemia > 140 mg/dL, hyperglycemia > 180 mg/dL, poor glycemic control, and intravenous insulin therapy were significantly associated with mortality. Patients with high glycemic variability, defined as coefficient of variation (CV) > 36%, had higher mortality than those with lower variability. In multivariable analysis, mean glucose remained the most robust glycemic predictor associated with mortality, while glycemic variability retained prognostic relevance in alternative models. Conclusions: Glycemic dysregulation was common and clinically relevant in critically ill diabetic and non-diabetic patients. Dynamic glucose monitoring, including mean glucose and glycemic variability, may improve risk stratification and support structured ICU glycemic management.